Insider Transactions in Q1 2024 at Silverback Therapeutics, Inc. (SBTX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
505,954
+4.84%
|
$4,553,586
$9.79 P/Share
|
|
Mar 26
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
457,745
+4.62%
|
$4,119,705
$9.55 P/Share
|
|
Mar 25
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
437,600
+4.64%
|
$3,938,400
$9.06 P/Share
|
|
Mar 25
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
95,267
-2.56%
|
$857,403
$9.12 P/Share
|
|
Mar 25
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
95,267
-2.56%
|
$857,403
$9.12 P/Share
|
|
Mar 22
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
2,343
-0.06%
|
$21,087
$9.02 P/Share
|
|
Mar 22
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
2,343
-0.06%
|
$21,087
$9.02 P/Share
|
|
Mar 21
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
472
-0.01%
|
$4,248
$9.0 P/Share
|
|
Mar 21
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
472
-0.01%
|
$4,248
$9.0 P/Share
|
|
Mar 19
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
1,918
-0.05%
|
$17,262
$9.04 P/Share
|
|
Mar 19
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
1,918
-0.05%
|
$17,262
$9.04 P/Share
|
|
Mar 15
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
96,756
-2.57%
|
$870,804
$9.14 P/Share
|
|
Mar 15
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
96,756
-2.57%
|
$870,804
$9.14 P/Share
|
|
Mar 14
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
444
-0.01%
|
$3,996
$9.0 P/Share
|
|
Mar 14
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
444
-0.01%
|
$3,996
$9.0 P/Share
|
|
Mar 13
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
2,800
-0.07%
|
$25,200
$9.0 P/Share
|
|
Mar 13
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
2,800
-0.07%
|
$25,200
$9.0 P/Share
|
|
Feb 29
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
3,782
-0.07%
|
$34,038
$9.02 P/Share
|
|
Feb 29
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
3,782
-0.07%
|
$34,038
$9.02 P/Share
|
|
Feb 28
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
98,778
-1.71%
|
$889,002
$9.02 P/Share
|
|
Feb 28
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
98,778
-1.71%
|
$889,002
$9.02 P/Share
|
|
Feb 26
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
700
-0.01%
|
$6,300
$9.01 P/Share
|
|
Feb 26
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
700
-0.01%
|
$6,300
$9.01 P/Share
|